First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T … – Newswise (press release)
|
First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T …
Newswise (press release) The new phase 1 pilot study, PLAT-03, will examine the feasibility and safety of administering a second T-cell product intended to increase the long-term persistence of the patient's chimeric antigen receptor (CAR) T cells that were reprogrammed to … |
